Bright Minds Price To Book vs. Net Income
| DRUG Stock | USD 86.15 0.85 0.98% |
For Bright Minds profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bright Minds to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bright Minds Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bright Minds's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bright Minds Biosciences over time as well as its relative position and ranking within its peers.
Check out Investing Opportunities. Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bright Minds Biosciences Net Income vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bright Minds's current stock value. Our valuation model uses many indicators to compare Bright Minds value to that of its competitors to determine the firm's financial worth. Bright Minds Biosciences is rated # 2 in price to book category among its peers. It is one of the top stocks in net income category among its peers . At this time, Bright Minds' Net Loss is most likely to decrease significantly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bright Minds by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Bright Net Income vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Bright Minds |
| = | 13.83 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Bright Minds |
| = | (12.23 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Bright Net Income Comparison
Bright Minds is currently under evaluation in net income category among its peers.
Bright Minds Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bright Minds, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bright Minds will eventually generate negative long term returns. The profitability progress is the general direction of Bright Minds' change in net profit over the period of time. It can combine multiple indicators of Bright Minds, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 4.4 M | 2.4 M | |
| Operating Income | -12.5 M | -11.9 M | |
| Income Before Tax | -11 M | -10.5 M | |
| Total Other Income Expense Net | 2 M | 2.1 M | |
| Net Loss | -13.5 M | -12.8 M | |
| Net Loss | -11 M | -10.5 M | |
| Income Tax Expense | -16.3 K | -15.5 K | |
| Net Interest Income | 1.7 M | 1.8 M | |
| Net Loss | -11 M | -11.6 M | |
| Interest Income | 1.7 M | 1.8 M | |
| Change To Netincome | 744.8 K | 548.8 K | |
| Net Loss | (2.04) | (2.15) | |
| Income Quality | 0.64 | 0.59 | |
| Net Income Per E B T | 0.91 | 0.80 |
Bright Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bright Minds. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bright Minds position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bright Minds' important profitability drivers and their relationship over time.
Bright Minds Earnings Estimation Breakdown
The calculation of Bright Minds' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bright Minds is estimated to be -1.185 with the future projection ranging from a low of -1.53 to a high of -0.91. Please be aware that this consensus of annual earnings estimates for Bright Minds Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-1.53 Lowest | Expected EPS | -0.91 Highest |
Bright Minds Earnings Projection Consensus
Suppose the current estimates of Bright Minds' value are higher than the current market price of the Bright Minds stock. In this case, investors may conclude that Bright Minds is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bright Minds' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 7 | 28.02% | -0.58 | -1.185 | -1.3 |
Bright Minds Earnings per Share Projection vs Actual
Actual Earning per Share of Bright Minds refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bright Minds Biosciences predict the company's earnings will be in the future. The higher the earnings per share of Bright Minds, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Bright Minds Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Bright Minds, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bright Minds should always be considered in relation to other companies to make a more educated investment decision.Bright Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Bright Minds' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-09-30 | 2025-09-30 | -0.9975 | -0.58 | 0.4175 | 41 | ||
2025-08-14 | 2025-06-30 | -0.882 | -0.74 | 0.142 | 16 | ||
2025-05-15 | 2025-03-31 | -0.46 | -0.42 | 0.04 | 8 | ||
2025-02-13 | 2024-12-31 | -0.5 | 0.01 | 0.51 | 102 | ||
2024-11-27 | 2024-09-30 | -0.6 | -0.17 | 0.43 | 71 | ||
2023-08-14 | 2023-06-30 | 0 | -0.2879 | -0.2879 | 0 | ||
2023-05-15 | 2023-03-31 | 0 | -0.0801 | -0.0801 | 0 | ||
2023-02-07 | 2022-12-31 | 0 | -0.0959 | -0.0959 | 0 | ||
2022-12-28 | 2022-09-30 | 0 | -0.152 | -0.152 | 0 |
Use Bright Minds in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bright Minds position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will appreciate offsetting losses from the drop in the long position's value.Bright Minds Pair Trading
Bright Minds Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Bright Minds could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bright Minds when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bright Minds - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bright Minds Biosciences to buy it.
The correlation of Bright Minds is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bright Minds moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bright Minds Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bright Minds can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bright Minds position
In addition to having Bright Minds in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Penny Thematic Idea Now
Penny
Solid stocks, funds or ETFs with below average market capitalization and typicl daily price below 2. The Penny theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Penny Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
To fully project Bright Minds' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bright Minds Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bright Minds' income statement, its balance sheet, and the statement of cash flows.